Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
Medical Health Encyclopedia
 border=



Medications

Chemotherapy uses drugs that kill cancer cells throughout the body. There are two situations in which chemotherapy is used:

  • The adjuvant setting. Adjuvant refers to the use of chemotherapy after surgery in patients with stage III tumors and selected patients with high-risk stage II tumors (i.e., disease that is potentially curable). The goal of this therapy is to eliminate any cancer cells that surgery may have missed, thereby preventing recurrence and increasing the chance of cure. Patients of all ages, including the elderly, can benefit.
  • In metastatic disease. In patients with metastatic disease the goal of chemotherapy is to shrink tumors, improve symptoms and quality of life, and to lengthen life.

In the adjuvant setting, there are some differences in chemotherapy treatments between colon and rectal cancers:

  • Chemotherapy for Stage II patients is considered standard care for stage II rectal cancer but is under debate for colon cancer.
  • Chemotherapy is standard for stage III colon cancer patients. Chemotherapy is also standard for stage III rectal cancer patients but is used in combination with radiation.
Text Continues Below



Chemotherapy for Stage II Patients with Colon Cancer. Adjuvant chemotherapy for Stage II colon cancer patients is controversial. Such patients tend to have a good outcome after surgery and the positive effects of chemotherapy have been difficult to demonstrate. To date, the survival advantage of adjuvant chemotherapy in this group has been reported to be only in the range of 2%. However, better trials are still needed to confirm or refute the benefits in specific patient groups.

Page:  1 | 2 | 3 | 4 | 5 | 6 | 7 | Next >>

 







About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy